Neurotez Inc. is a privately held Delaware corporation formed to launch the clinical development of Leptin as a hormone replacement therapy for Alzheimer's disease ("AD"), and as a preventative remedy for those at risk. While this program has a potential for high impact in healthcare in the short term, the building of a fully-integrated company, with a platform including discovery efforts to proof of concept clinical trials is our long term aim.
View Top Employees from Neurotez, Inc.Website | http://www.neurotez.com |
Revenue | $1 million |
Employees | 5 (1 on RocketReach) |
Founded | 2005 |
Address | 990 Highway 22 Suite 200A, Bridgewater, New Jersey 08807, US |
Phone | (908) 998-1340 |
Technologies |
JavaScript,
HTML,
PHP
+3 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Biotechnology, Business Services, Science and Engineering, Health Care, Medical, Therapeutics |
Web Rank | 16 Million |
Keywords | Neurotez Inc |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 54 Companies, NAICS Code 5417 Companies, NAICS Code 54171 Companies, NAICS Code 541 Companies, NAICS Code 541714 Companies |
Looking for a particular Neurotez, Inc. employee's phone or email?
The Neurotez, Inc. annual revenue was $1 million in 2024.
Jane Johnston is the Vice President Operations of Neurotez, Inc..
1 people are employed at Neurotez, Inc..
Neurotez, Inc. is based in Bridgewater, New Jersey.
The NAICS codes for Neurotez, Inc. are [54, 5417, 54171, 541, 541714].
The SIC codes for Neurotez, Inc. are [87, 873].